Chong Chang il 28/02/2026

Therapeutic base editing alleviates restrictive cardiomyopathy

Cell Rep Med. 2026 Feb 27:102639. doi: 10.1016/j.xcrm.2026.102639. Online ahead of print.ABSTRACTRestrictive cardiomyopathy (RCM) is a severe cardiac disorder characterized by impaired ventricular filling and diastolic dysfunction, with mutations in sarcomeric proteins representing major causative f

Lukáš Opatřil il 10/02/2026

Comparison of pulmonary circulation parameters acquired by cardiovascular magnetic resonance with right heart catheterization and transthoracic echocardiography in patients with recent-onset dilated cardiomyopathy

PLoS One. 2026 Feb 10;21(2):e0341438. doi: 10.1371/journal.pone.0341438. eCollection 2026.ABSTRACTINTRODUCTION: Evaluating pulmonary circulation parameters (PCP) with cardiovascular magnetic resonance (CMR) is a relatively new approach with the potential for complex evaluation of the cardio-pulmonar

Arancha Díaz Expósito il 29/01/2026

Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case report

Eur Heart J Case Rep. 2025 Nov 27;9(12):ytaf608. doi: 10.1093/ehjcr/ytaf608. eCollection 2025 Dec.ABSTRACTBACKGROUND: Cardiac transthyretin amyloidosis (ATTR-CM) is an infiltrative cardiomyopathy leading to restrictive physiology and, in advanced stages, systolic dysfunction. Conventional heart fail